These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents. Walder M Antimicrob Agents Chemother; 1979 Jul; 16(1):37-9. PubMed ID: 475372 [TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone. Tutlane VA; McCloskey RV; Trent JA Antimicrob Agents Chemother; 1981 Jul; 20(1):140-3. PubMed ID: 6269481 [TBL] [Abstract][Full Text] [Related]
11. The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes. Ahonkhai VI; Sierra MF; Cherubin CE; Shulman MA J Antimicrob Chemother; 1982 May; 9(5):411-2. PubMed ID: 6284696 [No Abstract] [Full Text] [Related]
12. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation. Karmali MA; De Grandis S; Fleming PC Antimicrob Agents Chemother; 1980 Dec; 18(6):948-51. PubMed ID: 7235681 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility pattern of Campylobacter jejuni from human and animal origins to different antimicrobial agents. Vanhoof R; Goossens H; Coignau H; Stas G; Butzler JP Antimicrob Agents Chemother; 1982 Jun; 21(6):990-2. PubMed ID: 7114842 [TBL] [Abstract][Full Text] [Related]
14. Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Wang WL; Reller LB; Blaser MJ Antimicrob Agents Chemother; 1984 Sep; 26(3):351-3. PubMed ID: 6508265 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Verbist L; Verhaegen J Antimicrob Agents Chemother; 1981 Mar; 19(3):402-6. PubMed ID: 6264844 [TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Nocardia asteroides to N-formimidoyl thienamycin and several cephalosporins. Cynamon MH; Palmer GS Antimicrob Agents Chemother; 1981 Dec; 20(6):841-2. PubMed ID: 7034644 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory and lethal activities of rosaramicin, erythromycin, and clindamycin against Campylobacter fetus subsp jejuni and intestinalis. Smith JA; Isaac-Renton JL; Jellett JF; Chow AW; Ngui-Yen J Am J Vet Res; 1983 Aug; 44(8):1605-6. PubMed ID: 6625312 [TBL] [Abstract][Full Text] [Related]
18. [Sensitivity of Campylobacter to 2 new groups of beta-lactams]. Belbouri A; Novo Y; Megraud F Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):675-7. PubMed ID: 3054745 [TBL] [Abstract][Full Text] [Related]
19. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics. Hanslo D; King A; Shannon K; Warren C; Phillips I J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426 [No Abstract] [Full Text] [Related]
20. Susceptibility of Campylobacter fetus subsp. jejuni, isolated from patients in Jakarta, Indonesia to ten antimicrobial agents. Ringertz S; Rockhill RC; Ringertz O J Antimicrob Chemother; 1981 Oct; 8(4):333-6. PubMed ID: 7298551 [No Abstract] [Full Text] [Related] [Next] [New Search]